New Survey Reveals What Women in the U.S. Really Want to Know About
BOTOX® Cosmetic (onabotulinumtoxinA)

Irvine, Calif., (November 11, 2014) / PR Newswire / — Many women are familiar with the brand name BOTOX® Cosmetic (onabotulinumtoxinA), but a new study from SheSpeaks™, an online community of women, reveals what they really want to know about it.1 To address the most common questions women have – and there are nearly 10 million women who are considering treatment2 – Allergan Inc., maker of BOTOX® Cosmetic, teamed up with SheSpeaks to identify these questions and provide answers.
Read More

“BOTOX® Cosmetic has been on the market for more than 12 years and is the number one selling prescription treatment in the country for the temporary improvement of both moderate to severe frown lines between the brows and crow’s feet lines,3” said Dr. Anthony Youn, Board Certified Plastic Surgeon. “Every day in my practice I have patients ask me for more information about the treatment. I find it interesting that many women don’t know that much about it.”

According to the survey of more than 2,200 women, 54 percent want to learn how much BOTOX® Cosmetic costs.1 “Many of my patients believe that BOTOX® Cosmetic is more expensive than it is,” said Dr. Youn. “Patients don’t realize that the cost of treatment not only includes the price of the product but, more importantly, the skill and expertise of the healthcare professional who is administering the treatment.”

Additionally, women are concerned their face will not look natural after treatment (18 percent of women) and want to know more about the safety of the product (36 percent of women).1 “BOTOX® Cosmetic is a widely studied treatment in the field of medical aesthetics,” said Dr. Elizabeth Hale, Board Certified Dermatologist.  “When BOTOX® Cosmetic is performed by a licensed and trained healthcare professional who has experience with the product and knowledge of facial anatomy, it will not radically change your facial appearance or make you look like you had ‘work done’.”

“Based on data from 15 years of published clinical studies4, physicians like myself have come to rely on the precise, predictable results BOTOX® Cosmetic provides,” said Dr. Hale. “Because there are certain risks and side effects that can be associated with the treatment, it is important to go to someone that is properly trained and who you have thoroughly researched and trust.”

As part of this initiative to further educate consumers, a new BOTOX® Cosmetic treatment visualizer app is also available for the iPad®. The Allergan iVisualizer app lets you take a photo of your vertical frown lines – or a video of your crow’s feet lines – and visualize what your frown lines between the eyebrows and crow’s feet would look like after a BOTOX® Cosmetic treatment. The Allergan iVisualizer app and can be downloaded for the iPad® via iTunes®.

BOTOX® Cosmetic has also launched a newly designed website, www.botoxcosmetic.com, to address top questions about the product. The website also features a before and after gallery of women and men who received treatment and helps patients who are interested find local physicians and enroll in the Brilliant Distinctions® rewards program. Patients who enroll in Brilliant Distinctions® earn points on every BOTOX® Cosmetic treatment that can be redeemed for future savings.

The SheSpeaks™ Survey results will be available on www.botoxcosmetic.com later this year. For more information on SheSpeaks™, an online womens’ community, visit www.Shespeaks.com.

BOTOX® Cosmetic (onabotulinumtoxinA) Important Information

Approved Uses
BOTOX® Cosmetic is a prescription medicine that is injected into muscles and used to temporarily improve the look of both moderate to severe crow’s feet lines and frown lines between the eyebrows in adults.

IMPORTANT SAFETY INFORMATION
BOTOX® Cosmetic may cause serious side effects that can be life threatening. Call your doctor or get medical help right away if you have any of these problems any time (hours to weeks) after injection of BOTOX® Cosmetic:

  • Problems swallowing, speaking, or breathing, due to weakening of associated muscles, can be severe and result in loss of life. You are at the highest risk if these problems are pre-existing before injection. Swallowing problems may last for several months
  • Spread of toxin effects. The effect of botulinum toxin may affect areas away from the injection site and cause serious symptoms including: loss of strength and all-over muscle weakness, double vision, blurred vision and drooping eyelids, hoarseness or change or loss of voice, trouble saying words clearly, loss of bladder control, trouble breathing, trouble swallowing. If this happens, do not drive a car, operate machinery, or do other dangerous activities

The dose of BOTOX® Cosmetic is not the same as, or comparable to, any other botulinum toxin product.

There has not been a confirmed serious case of spread of toxin effect when BOTOX® Cosmetic has been used at the recommended dose to treat frown lines, crow’s feet lines or both at the same time.

Serious and/or immediate allergic reactions have been reported. They include: itching, rash, red itchy welts, wheezing, asthma symptoms, or dizziness or feeling faint. Tell your doctor or get medical help right away if you are wheezing or have asthma symptoms, or if you become dizzy or faint.

Do not take BOTOX® Cosmetic if you: are allergic to any of the ingredients in BOTOX® Cosmetic (see Medication Guide for ingredients); had an allergic reaction to any other botulinum toxin product such as Myobloc® (rimabotulinumtoxinB), Dysport® (abobotulinumtoxinA), or Xeomin® (incobotulinumtoxinA); have a skin infection at the planned injection site.

Tell your doctor about all your muscle or nerve conditions, such as amyotrophic lateral sclerosis (ALS or Lou Gehrig’disease), myasthenia gravis, or Lambert-Eaton syndrome, as you may be at increased risk of serious side effects including difficulty swallowing and difficulty breathing from typical doses of BOTOX® Cosmetic.

Tell your doctor about all your medical conditions, including: plans to have surgery; had surgery on your face; weakness of forehead muscles, such as trouble raising your eyebrows; drooping eyelids; any other abnormal facial change; are pregnant or plan to become pregnant (it is not known if BOTOX® Cosmetic can harm your unborn baby); are breast-feeding or plan to breast-feed (it is not known if BOTOX® Cosmetic passes into breast milk).

Tell your doctor about all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal products. Using BOTOX® Cosmetic with certain other medicines may cause serious side effects. Do not start any new medicines until you have told your doctor that you have received BOTOX® Cosmetic in the past.

Especially tell your doctor if you: have received any other botulinum toxin product in the last 4 months; have received injections of botulinum toxin, such as Myobloc®, Dysport®, or Xeomin® in the past (be sure your doctor knows exactly which product you received); have recently received an antibiotic by injection; take muscle relaxants; take an allergy or cold medicine; take a sleep medicine; take aspirin-like products or blood thinners.

Other side effects of BOTOX® Cosmetic include: dry mouth, discomfort or pain at the injection site, tiredness, headache, neck pain, and eye problems: double vision, blurred vision, decreased eyesight, drooping eyelids, swelling of your eyelids, and dry eyes.

For more information refer to the Medication Guide or talk with your doctor.

To report a side effect, please call Allergan at 1-800-433-8871.

Please see BOTOX® Cosmetic full Product Information including Boxed Warning and Medication Guide.

About Allergan
Allergan is a multi-specialty health care company established more than 60 years ago with a commitment to uncover the best of science and develop and deliver innovative and meaningful treatments to help people reach their life’s potential. Today, we have approximately 11,500 highly dedicated and talented employees, global marketing and sales capabilities with a presence in more than 100 countries, a rich and ever-evolving portfolio of pharmaceuticals, biologics, medical devices and over-the-counter consumer products, and state-of-the-art resources in R&D, manufacturing and safety surveillance that help millions of patients see more clearly, move more freely and express themselves more fully. From our beginnings as an eye care company to our focus today on several medical specialties, including eye care, neurosciences, medical aesthetics, medical dermatology, breast aesthetics and urologics, Allergan is proud to celebrate more than 60 years of medical advances and proud to support the patients and physicians who rely on our products and the employees and communities in which we live and work. For more information regarding Allergan, go to: www.allergan.com.

© 2014 Allergan, Inc. Irvine, CA 92612
® marks owned by Allergan, Inc.

SheSpeaks® is a registered trademark of SheSpeaks Incorporated.
iPad® and iTunes® are registered trademarks of Apple Inc.
Dysport® is a registered trademark of Ipsen Biopharm Limited.
Myobloc® is a registered trademark of Solstice Neurosciences, Inc.
Xeomin® is a registered trademark of Merz Pharma GmbH & Co, KGaA.

Forward-Looking Statements
This press release contains “forward-looking statements,” including but not limited to, the statements by Dr. Youn and Dr. Hale as well as other statements regarding the safety and efficacy of BOTOX®. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Allergan’s expectations and projections. Risks and uncertainties include, among other things, general industry and pharmaceutical market conditions; challenges related to achieving regulatory approval from the FDA on a timely and cost‐efficient manner; technological advances and patents attained by competitors; inconsistency of treatment results among patients; potential difficulties in manufacturing; challenges related to new product marketing, such as the unpredictability or market acceptance for new products and/or the acceptance of new indications for such products; and governmental laws and regulations affecting domestic and foreign operations. Allergan expressly disclaims any intent or obligation to update these forward-looking statements except as required by law. Additional information concerning these and other risks can be found in press releases issued by Allergan, as well as Allergan’s public periodic filings with the U.S. Securities and Exchange Commission, including the discussion under the heading “Risk Factors” in Allergan’s most recent Annual Report on Form 10‐K and any subsequent Quarterly Reports on Form 10‐Q. Copies of Allergan’s press releases and additional information about Allergan are available at www.allergan.com.

Allergan Contacts
Bonnie Jacobs (856) 912-9965; (714) 246-5134 (media);  [email protected]
Lanie Shapero, (732) 991-4368; (908) 203-2631 (media); [email protected]

References
1 SheSpeaks BOTOX® Cosmetic Survey 2014
2 Allergan Data on File Facial Injectable Patient Funnel
3 Allergan Data on File, Market Overview Worldwide, 2013
4 Allergan Data on File, Patient Clinicals, 2014

APC77GT14